Zhang et al., 2019 - Google Patents
Ultrasensitive detection of circulating tumor DNA of lung cancer via an enzymatically amplified SERS-based frequency shift assayZhang et al., 2019
- Document ID
- 6729864268372760274
- Author
- Zhang J
- Dong Y
- Zhu W
- Xie D
- Zhao Y
- Yang D
- Li M
- Publication year
- Publication venue
- ACS applied materials & interfaces
External Links
Snippet
Circulating tumor DNA (ctDNA) is a promising noninvasive biomarker for the early diagnosis of cancers. However, it is challenging for accurate and sensitive detection of pico-to- femtomolar serum concentration of ctDNA, especially in the presence of its analogues that …
- 229920003013 deoxyribonucleic acid 0 title abstract description 206
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N21/658—Raman scattering enhancement Raman, e.g. surface plasmons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the means of detection
- C12Q1/6825—Nucleic acid detection involving sensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Ultrasensitive detection of circulating tumor DNA of lung cancer via an enzymatically amplified SERS-based frequency shift assay | |
Miao et al. | Dumbbell hybridization chain reaction based electrochemical biosensor for ultrasensitive detection of exosomal miRNA | |
Bellassai et al. | Surface plasmon resonance for biomarker detection: advances in non-invasive cancer diagnosis | |
Zhou et al. | Detection of circulating tumor DNA in human blood via DNA-mediated surface-enhanced Raman spectroscopy of single-walled carbon nanotubes | |
Nie et al. | Versatile and ultrasensitive electrochemiluminescence biosensor for biomarker detection based on nonenzymatic amplification and aptamer-triggered emitter release | |
Ma et al. | Construction of a robust entropy-driven DNA nanomachine for single-molecule detection of rare cancer cells | |
Si et al. | Catalytic hairpin self-assembly-based SERS sensor array for the simultaneous measurement of multiple cancer-associated miRNAs | |
Nie et al. | Low-fouling surface plasmon resonance sensor for highly sensitive detection of microRNA in a complex matrix based on the DNA tetrahedron | |
Qu et al. | Dual-aptamer modification generates a unique interface for highly sensitive and specific electrochemical detection of tumor cells | |
Koo et al. | Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction | |
Sornambikai et al. | systematic review on electrochemical biosensing of breast cancer miRNAs to develop alternative DCIS diagnostic tool | |
Iliuk et al. | Aptamer in bioanalytical applications | |
Qiang et al. | Aptamer/polydopamine nanospheres nanocomplex for in situ molecular sensing in living cells | |
Zhang et al. | Visual and highly sensitive detection of cancer cells by a colorimetric aptasensor based on cell-triggered cyclic enzymatic signal amplification | |
Yin et al. | A multifunctional platform for the capture, release, and enumeration of circulating tumor cells based on aptamer binding, nicking endonuclease-assisted amplification, and inductively coupled plasma mass spectrometry detection | |
Choi et al. | Nanomaterial-based fluorescence resonance energy transfer (FRET) and metal-enhanced fluorescence (MEF) to detect nucleic acid in cancer diagnosis | |
Guo et al. | Tetrahedron probes for ultrasensitive in situ detection of telomerase and surface glycoprotein activity in living cells | |
Wang et al. | Immunomagnetic antibody plus aptamer pseudo-DNA nanocatenane followed by rolling circle amplication for highly-sensitive CTC detection | |
Sun et al. | Combination of immunomagnetic separation with aptamer-mediated double rolling circle amplification for highly sensitive circulating tumor cell detection | |
Chen et al. | Simultaneous homogeneous fluorescence detection of AFP and GPC3 in hepatocellular carcinoma clinical samples assisted by enzyme-free catalytic hairpin assembly | |
Wang et al. | Algorithm-assisted detection and imaging of microRNAs in living cancer cells via the disassembly of plasmonic core-satellite probes coupled with strand displacement amplification | |
Palchetti | Affinity biosensors for tumor-marker analysis | |
Jiang et al. | Current research status of tumor cell biomarker detection | |
Jiang et al. | Nanoarchitectonics-assisted simultaneous fluorescence detection of urinary dual miRNAs for noninvasive diagnosis of prostate cancer | |
Sun et al. | Ratiometric fluorescent biosensor based on forster resonance energy transfer between carbon dots and acridine orange for miRNA analysis |